Literature DB >> 5437892

Comparison of antibiotics in the treatment of mycoplasmal pneumonia.

J M Shames, R B George, W B Holliday, J R Rasch, W J Mogabgab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5437892

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  23 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas.

Authors:  P Erb; W Bredt
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 3.  The sore throat. When to investigate and when to prescribe.

Authors:  S D Lang; K Singh
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  Oral antibiotics versus parenteral antibiotics for severe pneumonia in children.

Authors:  M X Rojas; C Granados
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

5.  Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

6.  Species-specific monoclonal antibody to a 43,000-molecular-weight membrane protein of Mycoplasma pneumoniae.

Authors:  R D Madsen; F A Saeed; O Gray; B M Fendly; S R Coates
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

7.  Possible influence of antibiotic therapy on usefulness of metabolic inhibition test for diagnosis of Mycoplasma pneumoniae infections.

Authors:  T F Smith; E C Herrmann
Journal:  Appl Microbiol       Date:  1971-01

8.  In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.

Authors:  K Ishida; M Kaku; K Irifune; R Mizukane; H Takemura; R Yoshida; H Tanaka; T Usui; N Suyama; K Tomono
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.

Authors:  M Kaku; K Ishida; K Irifune; R Mizukane; H Takemura; R Yoshida; H Tanaka; T Usui; K Tomono; N Suyama
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 10.  Mycoplasma pneumoniae infections of adults and children.

Authors:  J D Cherry; R C Welliver
Journal:  West J Med       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.